Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.
Isabelle
I
Raingeard
Philippe
P
Courtet
Eric
E
Renard
Jacques
J
Bringer
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D002032:Bulimia / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000523:psychology; D002149:Energy Intake; D001068:Feeding and Eating Disorders / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D009271:Naltrexone; D009292:Narcotic Antagonists